Text & Content Analysis
Context:
entity
(vosoritide shows sustained height gains)
|
Window:
24h ·
7d ·
30d
|
Corpus:
1 articles
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
vosoritide shows sustained height gains
Articles
1
From
2026-05-03 06:50:01+00
To
2026-05-03 06:50:01+00
Range
2026-05-02 11:59:56.577083+00 →
2026-05-03 11:59:56.577083+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| 5m | MONEY | 1 | 📊 🔍 🧲 |
| achondroplasia | PERSON | 1 | 📊 🔍 🧲 |
| aposemaglutide injection | ORG | 1 | 📊 🔍 🧲 |
| apotex | GPE | 1 | 📊 🔍 🧲 |
| biomarin | ORG | 1 | 📊 🔍 🧲 |
| british columbias | ORG | 1 | 📊 🔍 🧲 |
| canada | GPE | 1 | 📊 🔍 🧲 |
| canadian | NORP | 1 | 📊 🔍 🧲 |
| glp1 | ORG | 1 | 📊 🔍 🧲 |
| health canada | ORG | 1 | 📊 🔍 🧲 |
| health canadas | ORG | 1 | 📊 🔍 🧲 |
| indian | NORP | 1 | 📊 🔍 🧲 |
| jon | PERSON | 1 | 📊 🔍 🧲 |
| jon napitupulu | PERSON | 1 | 📊 🔍 🧲 |
| jon napitupulu lifestyle program improves brain health | ORG | 1 | 📊 🔍 🧲 |
| media relations | ORG | 1 | 📊 🔍 🧲 |
| ontario | GPE | 1 | 📊 🔍 🧲 |
| orbicular pharmaceutical technologies | ORG | 1 | 📊 🔍 🧲 |
| ozempic | ORG | 1 | 📊 🔍 🧲 |
| pharmacare | ORG | 1 | 📊 🔍 🧲 |
| schizophrenia | PERSON | 1 | 📊 🔍 🧲 |
| sku | ORG | 1 | 📊 🔍 🧲 |
| sku novo nordisk | ORG | 1 | 📊 🔍 🧲 |
| vosoritide shows sustained height gains | ORG | 1 | 📊 🔍 🧲 |
Who’s talking
Top Sources (Domains)
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 100.00 | 📊 📰 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-05-03 06:50:01+00 | Health |
|
Apotex Gets Health Canada Approval for Generic Semaglutide | Analyze | Jon Napitupulu | 😐 neutral | 0.1055 |